"Carbenoxolone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.
| Descriptor ID |
D002229
|
| MeSH Number(s) |
D02.455.849.919.530.444.250
|
| Concept/Terms |
Carbenoxolone Sodium- Carbenoxolone Sodium
- Carbenoxolone Disodium Salt
- Glycyrrhetinic Acid 3-O-hemisuccinate
- 3-O-hemisuccinate, Glycyrrhetinic Acid
- Acid 3-O-hemisuccinate, Glycyrrhetinic
- Glycyrrhetinic Acid 3 O hemisuccinate
18alpha-Carbenoxolone- 18alpha-Carbenoxolone
- 18alpha Carbenoxolone
- 18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate
- 18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate
- 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid
- Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic
|
Below are MeSH descriptors whose meaning is more general than "Carbenoxolone".
Below are MeSH descriptors whose meaning is more specific than "Carbenoxolone".
This graph shows the total number of publications written about "Carbenoxolone" by people in this website by year, and whether "Carbenoxolone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbenoxolone" by people in Profiles.
-
Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy. Neuroscience. 2015 Jan 29; 285:1-10.
-
Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain. 2013 Feb; 14(2):205-14.
-
Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab. 2007 Dec; 293(6):E1517-28.